Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Guillain-Barré Syndrome (GBS)”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Not applicableLooking for participantsNCT07653984
What this trial is testing

Cohort Study on Neuroimmune Diseases in the Reproductive Age

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)Multiple SclerosisAutoimmune Encephalitis+3 more
Third Affiliated Hospital, Sun Yat-Sen University 100
Large-scale testing (Phase 3)Looking for participantsNCT07020819
What this trial is testing

An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study)

Who this might be right for
Guillain-Barre Syndrome
Annexon, Inc. 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06885762
What this trial is testing

Efgartigimod for the Treatment of Guillain-Barré Syndrome

Who this might be right for
Guillain-Barre Syndrome (GBS)
Zhongming Qiu 20
Not applicableStudy completedNCT02883270
What this trial is testing

Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome

Who this might be right for
GBS
Junwei Hao 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07821762
What this trial is testing

Empasiprubart as Add-On Therapy to IVIg in Adult Participants With Guillain-Barré Syndrome

Who this might be right for
Guillain-Barré Syndrome (GBS)
argenx 63
Testing effectiveness (Phase 2)Study completedNCT03943589
What this trial is testing

Imlifidase in Patients With Guillain-Barré Syndrome

Who this might be right for
Guillain-Barré Syndrome (GBS)
Hansa Biopharma AB 30
Not applicableLooking for participantsNCT04829526
What this trial is testing

Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome

Who this might be right for
Guillain-Barre Syndrome (GBS)
University Hospital, Basel, Switzerland 100
Early research (Phase 1)Study completedNCT04035135
What this trial is testing

A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)

Who this might be right for
Guillain-Barré Syndrome
Annexon, Inc. 14
Early research (Phase 1)WithdrawnNCT03773328
What this trial is testing

A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)

Who this might be right for
Guillain-Barré Syndrome
Cellenkos, Inc.
Not applicableLooking for participantsNCT04871035
What this trial is testing

Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)

Who this might be right for
GBS
University of Ulm 20
Not applicableNot Yet RecruitingNCT07121985
What this trial is testing

Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
CIDP - Chronic Inflammatory Demyelinating PolyneuropathyGuillain-Barré Syndrome (GBS)
University of Erlangen-Nürnberg Medical School 30
Not applicableLooking for participantsNCT06615622
What this trial is testing

Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.

Who this might be right for
Guillain Barré SyndromeChronic Inflammatory Demyelinating PolyradiculoneuropathyPeripheral Nerve Disorder+2 more
Assiut University 90
Not applicableLooking for participantsNCT05212792
What this trial is testing

Genomics and COVID-19 Vaccine Adverse Events

Who this might be right for
Vaccine Adverse Reaction
University of British Columbia 6,325
Not applicableStudy completedNCT01582763
What this trial is testing

International Guillain-Barré Syndrome Outcome Study

Who this might be right for
Guillain-Barré SyndromeMiller Fisher Syndrome
Erasmus Medical Center 2,000
Large-scale testing (Phase 3)WithdrawnNCT05494619
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS)

Who this might be right for
Guillain-Barré Syndrome
Hoffmann-La Roche
Not applicableUnknownNCT02582853
What this trial is testing

SCD163 as a Potential Biomarker in Guillain- Barré Syndrome

Who this might be right for
Guillain-Barre Syndrome
University of Aarhus 60
Testing effectiveness (Phase 2)Study completedNCT02493725
What this trial is testing

JET-GBS - Japanese Eculizumab Trial for GBS

Who this might be right for
Gullain Barre Syndrome
Chiba University 34
Not applicableStudy completedNCT00575653
What this trial is testing

Safety Study of GBS Following Menactra Meningococcal Vaccination

Who this might be right for
Guillain-Barre Syndrome
Harvard Pilgrim Health Care 6,000,000
Not applicableLooking for participantsNCT06940908
What this trial is testing

Living With Guillain-Barré Syndrome as Children.

Who this might be right for
Guillain Barré SyndromeGuillain-Barré Syndrome (GBS)
University Hospital, Toulouse 25
Testing effectiveness (Phase 2)Study completedNCT02780570
What this trial is testing

Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) Patients

Who this might be right for
Guillain-Barré Syndrome
International Centre for Diarrhoeal Disease Research, Bangladesh 20
Next Page